Centene Raises 2026 Outlook on 2Q Profit, Revenue Growth

Dow Jones
07/28
 
 

Centene lifted its guidance for the year after revenue and profit growth in the second quarter were driven by strength in its core government-sponsored and individual healthcare lines.

The care and health insurance company on Tuesday said it now expects higher revenue in the year, driven largely by premium tax revenue, as well as its Marketplace and Medicaid businesses.

As a result, it now expects total revenues to be $6 billion higher, with a new range of $193.5 billion to $197.5 billion. Analysts expect $191.16 billion, according to FactSet.

Premium and service revenues guidance range was also increased by $2 billion to a new range of $173 billion to $177 billion.

At the same time, the company said its guidance floor was lifted to greater than $3.11 and its adjusted diluted EPS guidance floor to more than $4.80.

For the second quarter, Centene posted a net income of $1.09 billion, or $2.19 a share, compared with a loss of $253 million, or 51 cents a share, in the same quarter a year ago.

On an adjusted basis, which excludes one-off costs and exceptional items, earnings came to $2.51 a share. According to FactSet, analysts were expecting $1.08 a share.

Total revenues rose to $53.58 billion from $48.74 billion. Analysts expected a slight decline to $47.64 billion.

Premium and service revenues were $44.38 billion, compared with $42.47 billion, largely due to a 5% increase in Medicaid revenue, its largest contributor, and a 17% increase in Medicare.

Health benefits ratio, a key insurance metric showing the percentage of premium revenue spent on paying medical claims, came to 89.6%, down from 93% a year earlier. A lower ratio is better for profits. FactSet was expecting 91%.

 
 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10